RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 90 filers reported holding RELMADA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,930,105 | +22.0% | 1,310,035 | 0.0% | 0.00% | – |
Q2 2023 | $3,222,686 | -5.3% | 1,310,035 | -13.0% | 0.00% | – |
Q1 2023 | $3,401,253 | -35.8% | 1,504,979 | -0.8% | 0.00% | – |
Q4 2022 | $5,294,260 | -90.1% | 1,516,980 | +5.1% | 0.00% | -100.0% |
Q3 2022 | $53,456,000 | +97.8% | 1,443,960 | +1.5% | 0.00% | +100.0% |
Q2 2022 | $27,023,000 | -24.4% | 1,423,032 | +7.5% | 0.00% | 0.0% |
Q1 2022 | $35,736,000 | +29.5% | 1,324,014 | +8.1% | 0.00% | 0.0% |
Q4 2021 | $27,598,000 | +15.1% | 1,224,901 | +33.9% | 0.00% | 0.0% |
Q3 2021 | $23,975,000 | -3.0% | 914,723 | +18.5% | 0.00% | 0.0% |
Q2 2021 | $24,705,000 | +1.2% | 771,776 | +11.3% | 0.00% | 0.0% |
Q1 2021 | $24,411,000 | +14.9% | 693,307 | +4.6% | 0.00% | 0.0% |
Q4 2020 | $21,250,000 | -16.0% | 662,623 | -1.5% | 0.00% | 0.0% |
Q3 2020 | $25,311,000 | -18.2% | 672,781 | -2.7% | 0.00% | 0.0% |
Q2 2020 | $30,951,000 | +56.5% | 691,652 | +19.3% | 0.00% | 0.0% |
Q1 2020 | $19,779,000 | -11.0% | 579,858 | +1.8% | 0.00% | 0.0% |
Q4 2019 | $22,220,000 | – | 569,753 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
Savior LLC | 3,500 | $10,500 | 0.07% |
Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |